Abstract : We report a patient who developed Henoch -Schönlein purpura (HSP) 5 years after she presented with immunoglobulin A nephropathy (IgAN). A 10 -year -old Japanese female was identified with proteinuria and hematuria by a school urinary screening. The first renal biopsy showed mesangial proliferative glomerulonephritis with immunofluorescent findings consistent with IgAN. She was treated with prednisolone, warfarin, and dilazep dihydrochloride, and the proteinuria and hematuria disappeared 4 months after the onset of treatment. Five years later she developed abdominal pain, gross hematuria and a classic purpuric rash of HSP after acute pharyngitis. The second renal biopsy showed diffuse mesangial proliferation with cellular crescent formation, and the patient was treated with methylprednisolone pulse therapy, prednisolone and mizoribine, resulting in a gradual decrease in urinary protein excretion. Our patient is unusual in that she developed Henoch -Schönlein purpura nephritis 5 years after clinical and biopsy evidence of IgAN, which suggests that IgAN and HSP are different clinical manifestations of the same disease, probably sharing a common pathogenesis.
INTRODUCTION
The relationship between immunoglobulin A nephropathy (IgAN) and Henoch -Schönlein purpura nephritis (HSPN) has long been debated. It has been suggested that these two diseases are different clinical manifestations of the same disease, and probably sharing a common pathogenesis 1, 2) . Clinical observations supporting this hypothesis include the occurrence of these two diseases in the same family 3−5) and cases of patients presenting with a purpuric rash several years before the development of IgAN 6) . In addition, there have been a few reports of cases of the evolution of IgAN into HSPN.
We describe a 10 
CASE REPORT
Proteinuria and hematuria were detected by a school urinary screening in May 2003 when the patient was 10 years of age. The patient was referred to our hospital, where she was admitted. Evaluation on admission disclosed a normal physical examination. . Immunology studies revealed a serum IgA level of 132 mg/dl, C3 113 mg/dl, C4 17 mg/dl, CH50 31.9 U/ml, antinuclear antibody titer <160 X, and negativity for anti -DNA antibody. The renal biopsy was performed (Fig. 1) . Immunofluorescence microscopic examination revealed a predominant deposition of IgA with C3 in the mesangial area. Light microscopic examination showed diffuse mesangial proliferation and a small increase in the mesangial matrix. The patient was diagnosed with IgA nephropathy and was treated with daily oral administration of prednisolone (PSL, initially 1 mg/kg/day), warfarin, and dilazep dihydrochloride. After treatment, the patient's urinary protein excretion decreased and her microhematuria disappeared. The prednisolone treatment was subsequently tapered off after 24 months as the proteinuria and hematuria had completely disappeared. Regular urine analyses did not reveal any abnormalities for more than 3 years.
In 2008, the patient experienced abdominal pain and palpable purpura on the legs after acute pharyngitis. Two weeks later, hematuria and proteinuria appeared. Subsequently, the proteinuria gradually increased and macrohematuria was appeared. The patient was subsequently referred to our hospital. The results of laboratory tests are shown in Table 1 . A diagnosis of HSP was made on the basis of the palpable purpura, abdominal pain, proteinuria, and microhematuria. A second renal biopsy was performed, and immunofluorescence microscopic examination revealed a predominant deposition of IgA with C3 in the mesangial area. Light microscopic examination showed diffuse mesangial proliferation with cellular crescent formation. The patients was, therefore, diagnosed with HSPN of ISKDC grade III, and was treated with three courses of methylprednisolone pulse therapy (1,000 mg/day), followed by daily intravenous administration of PSL (60 mg/day) and mizoribine (MZB, 150mg/day in a single dose). Urinary protein excretion was 3.0 -3.5 g/day, gradually decreasing over the following 2 months to less than 0.5 g/day, and the administration of PSL was subsequently . On the other hand, most patients with IgAN experience persistent microscopic hematuria and intermittent episodes of gross hematuria, usually in association with an upper respiratory infection, with 15 -20% of the patients developing either renal failure or hypertensions. The diagnosis of IgAN is established by the presence of IgA deposits in the mesangium 8) . Immunologic studies in patients with HSP have revealed what is regarded as a characteristic feature : the presence of predominantly IgA deposits in the mesangium. The movement of skin and joints together with abdominal symptoms distinguish HSP from IgAN, which usually presents as isolated renal disease.
The possibility of a genetic predisposition to the development of HSP and/or IgAN has been suggested by the many studies on the occurrence of either HSP and/or IgAN within the same families 5, 6, 10) . Meadow and Scott reported the interesting evolution of two identical twin brothers who suffered an adenovirus infection at the same time : one of them developed HSP whereas the other presented with only renal manifestations, with the results of a renal biopsy characteristics of IgAN 3) . There have been occasional reports of the coexistence of HSP and IgAN in different members of the same family. In addition, some patients reported with IgAN had previously presented with bouts of purpuric rash 6) . Our present case is a 10 -year -old girl with IgAN who 5 years later developed the characteristic features of HSP. To date, there has only been one similar case reported, that of a child. We reviewed 4 cases of IgAN that 5 years later developed the characteristic features of HSP and examined the epidemiology and clinical signs of the adults and children involved. These published reports are listed in Table 2 . Three patients were male, and one female, and their ages ranged from 10 to 39 (mean 25.5±15.2) years. HSP occurred 2 to 12 (mean 7.2±4.6) years after the onset of IgAN. As to the clinical manifestations of HSP, 4 patients had purpura, 2 had arthralgia, and one had abdominal pain. Two of three patients had high serum IgA levels at 13, 14) . HSPN is similar to IgAN in that IgA1, but not IgA2, is found in the circulating immune complexes and in mesangial immune deposits 14) . 15, 16) . As in patients with IgAN, increased galactosedeficient IgA1 (Gd -IgA1) levels have been detected in patients with HSPN, but not in subjects with other glomerular diseases. Gd -IgA1 currently assumes a pivotal role in the pathogenesis of both IgAN and HSPN 17) . The mechanisms of renal injury by the Gd .
2) The Gd -IgA1 immunocomplex in the mesangial areas activates mesangial cells, which results in cell proliferation, and inflammatory and profibrogenic cytokine and chemokine production, suggesting a pivotal role in mesangial cell proliferation, matrix expansion, and inflammatory cell recruitment 21) . Our patient is unusual in that she developed HSPN 5 years after clinical and biopsy evidence of IgAN, which suggests that IgAN and HSP are different clinical manifestations of the same disease, probably sharing a common pathogenesis. 
